Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Dedicated Community Oncology Sites
Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.
Rare Diseases And The Integrated CDMO Support System
Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
ATLAS Label Translation Solution
By simplifying label requests, integrating expert translation and regulatory support, and enabling a fully paperless approval workflow, organizations can reduce turnaround times while maintaining high-quality label content.
 Life Sciences Meetings Need More Than Logistics
Life sciences meetings often extend beyond investigators’ meetings. Strong planning helps teams support clinical, commercial, governance, and internal programs without adding pressure to the host team.

Demystifying Cell And Gene Therapy Studies In Australia And The Broader APAC Region
11/17/2024

Though conducting your clinical trial in Australia may initially seem daunting, the benefits are ample. Australia is home to qualified CRO partners that will guide your CGT to regulatory success.
Effective Study Design And Execution Of Renal And Hepatic Impairment Trials
5/1/2026

Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
When Vendor Disruption Threatens Trial Timelines: What Sponsors Should Do Next
9/30/2026

When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC
12/6/2024

Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.
6 Steps To Help You Choose The Right Clinical Trial Partner
9/12/2025

The right digital partner can unlock speed, scale, and collaboration that can transform the future of your pipeline. Learn the six steps to help you choose the right partner for your trials.

Patient Travel And Logistics

Block Clinical provides a single point of contact for Patients and Sites who support them throughout their journey, from start to finish.
Human ADME Studies: Human Metabolism Data For Regulatory Submission

Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.
Introducing One Home for Sites™

One Home for Sites is a vendor-agnostic, sponsor-agnostic, aggregation platform that provides single sign-on and more. Become part of the only industry-wide solution to site tech overload.
Drug Safety And Pharmacovigilance Services

Navigating drug safety in the era of innovation-driven medicine

The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
Rescue Studies

Clinical trials frequently encounter delays, and rescue studies have become vital to address this challenge, especially in complex therapeutic areas.